Incidence of spinal muscular atrophy in Poland--more frequent than predicted?
- PMID: 20090376
- DOI: 10.1159/000275492
Incidence of spinal muscular atrophy in Poland--more frequent than predicted?
Abstract
Background: The application of molecular methods has enhanced and enlarged the diagnostics of spinal muscular atrophy (SMA) and its carriership. It allows for reliable epidemiological studies which are of importance to demography and genetic counseling.
Methods: This study sought to evaluate the incidence of SMA in Poland, on the basis of the prevalence of the SMN1 gene deletion carrier state in the general population, as well as an analysis of all cases of SMA diagnosed in the years 1998-2005.
Results: The prevalence of the SMN1 gene deletion carrier state was estimated at 1 per 35 persons (17/600), yielding an incidence of SMA equal to 1 per 4,900. By contrast, the incidence of SMA based on the results of the meta-analysis was an estimated 1 per 7,127 in Warsaw and 1 per 9,320 persons across Poland, suggesting that some cases of SMA remain undiagnosed. SMA1 predominated among the diagnoses, accounting for 69% of all cases.
Conclusion: A high prevalence of the SMN1 deletion carrier state in the general population indicates that SMA could be a more frequent disease than is predicted by the epidemiological data regarding diagnosed cases.
2010 S. Karger AG, Basel.
Similar articles
-
Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.Neurology. 2005 Nov 22;65(10):1631-5. doi: 10.1212/01.wnl.0000184506.61354.5b. Neurology. 2005. PMID: 16301493
-
Rapid diagnosis of spinal muscular atrophy using tetra-primer ARMS PCR assay: simultaneous detection of SMN1 and SMN2 deletion.Mol Cell Probes. 2010 Jun;24(3):138-41. doi: 10.1016/j.mcp.2009.12.001. Epub 2009 Dec 16. Mol Cell Probes. 2010. PMID: 20025960
-
Deletion analysis of SMN1 exon 7 alone may be necessary and sufficient for the diagnosis of spinal muscular atrophy.J Neurogenet. 2011 Mar;25(1-2):15-6. doi: 10.3109/01677063.2011.559561. Epub 2011 Feb 22. J Neurogenet. 2011. PMID: 21338334
-
Spinal muscular atrophy: molecular genetics and diagnostics.Expert Rev Mol Diagn. 2004 Jan;4(1):15-29. doi: 10.1586/14737159.4.1.15. Expert Rev Mol Diagn. 2004. PMID: 14711346 Review.
-
[Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment].Genetika. 2008 Oct;44(10):1325-37. Genetika. 2008. PMID: 19062530 Review. Russian.
Cited by
-
The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia.Front Genet. 2021 Dec 22;12:796862. doi: 10.3389/fgene.2021.796862. eCollection 2021. Front Genet. 2021. PMID: 35003227 Free PMC article.
-
Implementing a Global Expanded Access Program (EAP) for Infantile-Onset Spinal Muscular Atrophy (Type I): Understanding the Imperative, Impact and Challenges.J Neuromuscul Dis. 2019;6(2):227-231. doi: 10.3233/JND-190387. J Neuromuscul Dis. 2019. PMID: 31127730 Free PMC article.
-
Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.Orphanet J Rare Dis. 2021 Mar 24;16(1):150. doi: 10.1186/s13023-021-01771-y. Orphanet J Rare Dis. 2021. PMID: 33761963 Free PMC article.
-
The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.J Neuromuscul Dis. 2021;8(1):109-123. doi: 10.3233/JND-200563. J Neuromuscul Dis. 2021. PMID: 33104036 Free PMC article.
-
Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy.Am J Med Genet A. 2013 Apr;161A(4):679-86. doi: 10.1002/ajmg.a.35756. Epub 2013 Feb 26. Am J Med Genet A. 2013. PMID: 23443997 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical